Clinical Trial Update: Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of elagolix versus placebo or leuprorelin acetate in endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Elagolix (elagolix)
• Leuprorelin acetate (Leuprorelin acetate)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-10